STATE STREET CORP - ZENTALIS PHARMACEUTICALS INC ownership

ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 134 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of ZENTALIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$54,229,402
-39.0%
2,703,360
-14.3%
0.00%
-40.0%
Q2 2023$88,943,704
+82.6%
3,152,914
+11.3%
0.01%
+66.7%
Q1 2023$48,710,796
-60.8%
2,832,023
-54.1%
0.00%
-25.0%
Q4 2022$124,229,038
+101.2%
6,168,274
+116.4%
0.00%0.0%
Q3 2022$61,735,000
-29.6%
2,850,174
-8.6%
0.00%
-20.0%
Q2 2022$87,665,000
-8.7%
3,119,734
+50.0%
0.01%0.0%
Q1 2022$95,992,000
-15.2%
2,080,440
+54.5%
0.01%0.0%
Q4 2021$113,180,000
+31.4%
1,346,416
+4.2%
0.01%0.0%
Q3 2021$86,116,000
+20.9%
1,292,263
-3.5%
0.01%
+25.0%
Q2 2021$71,253,000
+11.8%
1,339,340
-8.8%
0.00%0.0%
Q1 2021$63,748,000
+37.7%
1,469,191
+64.8%
0.00%
+33.3%
Q4 2020$46,305,000
+776.5%
891,509
+451.7%
0.00%
Q3 2020$5,283,000
-19.9%
161,594
+17.7%
0.00%
Q2 2020$6,592,000137,2700.00%
Other shareholders
ZENTALIS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 2,426,095$111,940,0006.63%
Paradigm Biocapital Advisors LP 287,577$13,269,0003.51%
Avidity Partners Management LP 3,176,999$146,587,0003.05%
Integral Health Asset Management, LLC 215,000$9,920,0002.58%
Matrix Capital Management Company, LP 4,349,279$200,676,0002.41%
Affinity Asset Advisors, LLC 207,500$9,574,0001.53%
Ikarian Capital, LLC 202,203$9,329,0001.23%
Ghost Tree Capital, LLC 80,000$3,691,0000.80%
Eventide Asset Management 761,000$35,113,0000.55%
Perceptive Advisors 501,509$23,140,0000.46%
View complete list of ZENTALIS PHARMACEUTICALS INC shareholders